目次
- 静がんメソッド 消化器癌編
―目次―
1.SCC院内ガイドライン
2.レジメン・有害事象マネジメント
頭頸部癌
TPF
FP(or 5-FU+CBDCA)±?Cmab
Cmab+DTX+CDDP
weekly PTX
weekly PTX+Cmab
DTX
S-1
CDDP+RT
CBDCA+RT
Cmab+RT
食道癌
FP,FP+?RT
5-FU+CDGP
DTX
weekly PTX
胃 癌
S-1+CDDP
SOX
XELOX
XP+Tmab
S-1+CDDP+Tmab
S-1
5-FU+?-LV
MTX+5-FU
weekly PTX
weekly PTX+Ramucirumab
ABI007
CPT-11
biweekly CPT-11+CDDP
adj S-1
胆・膵癌
FOLFIRINOX(膵)
GEM+ABI007(膵)
GEM+Erlotinib(膵)
GEM+CDDP(胆)
Gemcitabine(膵)
S-1(胆・膵)
S-1+RT(膵)
adj GEM(膵)
adj S-1(胆・膵)
大腸癌
FOLFOXIRI
FOLFOXIRI+Bmab
FOLFOX
FOLFOX+Bmab
FOLFOX+Cmab/Pmab
FOLFIRI
FOLFIRI+Bmab
FOLFIRI+Cmab/Pmab
XELOX
XELOX+Bmab
SOX+Bmab
S-1
Capecitabine
Capecitabine+Bmab
CPT-11
CPT-11+Cmab
IRIS
Cmab/Pmab
Trifluridine
Regorafenib
adj Capecitabine
adj UFT/LV
5-FU+LV,adj 5-FU+LV
5-FU+LV+Bmab
adj FOLFOX
adj XELOX